Bernardo Wealth Planning’s Biogen BIIB Stock Holding History

Bernardo Wealth Planning’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-834	Closed	-$251K	–	148
2018 Q4	$251K	Buy	+834	New	+$266K	0.22%	110

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bernardo Wealth Planning's BIIB Position: Q1 2019 in Review

Bernardo Wealth Planning sold out of Biogen (BIIB) in Q1 2019, closing a stake of 834 shares — an estimated $251K sold.

Bernardo Wealth Planning first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $251K in Q4 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Bernardo Wealth Planning reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Bernardo Wealth Planning sold 834 Biogen shares in Q1 2019, an estimated $251K.
Bernardo Wealth Planning first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
Bernardo Wealth Planning's Biogen position peaked at $251K in Q4 2018.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Bernardo Wealth Planning's 13F filing for Q1 2019, filed 8 May 2019.